Advertisement

Reactions Weekly

, Volume 1734, Issue 1, pp 28–28 | Cite as

Alectinib/crizotinib

Histologic transformation of adenocarcinoma to squamous cell carcinoma following drug resistance: case report
Case report
  • 9 Downloads

Reference

  1. Park S, et al. Histologic transformation of ALK-rearranged adenocarcinoma to squamous cell carcinoma after treatment with ALK inhibitor. Lung Cancer 127: 66-68, Jan 2019. Available from: URL: http://doi.org/10.1016/j.lungcan.2018.11.027 - South KoreaCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations